((lipodystrophy OR lipoatrophy) AND hiv) AND ((clinical[Title/Abstract] AND trial[Title/Abstract]) OR clinical trials[MeSH Terms] OR clinical trial[Publication Type] OR random*[Title/Abstract] OR random allocation[MeSH Terms] OR therapeutic use[MeSH Subheading])

r-metHuLeptin does not improve HAART-induced lipoatrophy and the metabolic syndrome through altering circulating IGF and IGF binding protein levels: observational and interventional studies in humans.

Brennan A, Lee J, Tsiodras S, Chan J, Doweiko J, Karchmer A, Mantzoros C.

Eur J Endocrinol. 2008 Nov 24. [Epub ahead of print]

PMID: 19029226 [PubMed - as supplied by publisher]

Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patients.

Ryan P, Blanco F, García-Gascó P, García-Merchán J, Vispo E, Barreiro P, Labarga P, González-Lahoz J, Soriano V.

HIV Med. 2008 Nov 10. [Epub ahead of print]

PMID: 19018879 [PubMed - as supplied by publisher]

Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adults.

Carr A, Ritzhaupt A, Zhang W, Zajdenverg R, Workman C, Gatell JM, Cahn P, Chaves R.

AIDS. 2008 Nov 12;22(17):2313-21.

PMID: 18981770 [PubMed - in process]

Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.

Herasimtschuk AA, Westrop SJ, Moyle GJ, Downey JS, Imami N.

J Immune Based Ther Vaccines. 2008 Oct 31;6(1):7. [Epub ahead of print]

PMID: 18976455 [PubMed - as supplied by publisher]

Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction.

Mallon PW, Sedwell R, Rogers G, Nolan D, Unemori P, Hoy J, Samaras K, Kelleher A, Emery S, Cooper DA, Carr A; Rosey Investigators.

J Infect Dis. 2008 Dec 15;198(12):1794-1803.

PMID: 18954260 [PubMed - as supplied by publisher]

[Anhedonia and depressive symptomatology among HIV-infected patients with highly active antiretroviral therapies (ANRS-EN12-VESPA)]

Préau M, Bonnet A, Bouhnik AD, Fernandez L, Obadia Y, Spire B; VESPA.

Encephale. 2008 Sep;34(4):385-93. Epub 2007 Oct 24. French.

PMID: 18922241 [PubMed - indexed for MEDLINE]

Concerning "Effects of a supraphysiological dose of testosterone on physical function, fatigue, and mood in men with human immunodeficiency virus-associated weight loss".

Collazos J.

Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E988; author reply E989. No abstract available.

PMID: 18852150 [PubMed - indexed for MEDLINE]

Metabolic complications of HIV treatment; HIV-related lipodystrophy.

Bouvier G.

HIV Clin. 2000 Fall;12(4):14-5. No abstract available.

PMID: 18841627 [PubMed - indexed for MEDLINE]

Pathogenesis and treatment of lipodystrophy: what clinicians need to know.

Sattler FR.

Top HIV Med. 2008 Oct-Nov;16(4):127-33. Review.

PMID: 18838747 [PubMed - indexed for MEDLINE]

10:

The next generation of human growth hormone. How Serostim and tesamorelin measure up.

Grodeck B.

Posit Aware. 2008 Sep-Oct;19(5):28-32. No abstract available.

PMID: 18828236 [PubMed - indexed for MEDLINE]

11:

Lipodystrophy and quality of life of HIV-infected persons.

Guaraldi G, Murri R, Orlando G, Squillace N, Stentarelli C, Zona S, Garlassi E, Martínez E.

AIDS Rev. 2008 Jul-Sep;10(3):152-61. Review.

PMID: 18820717 [PubMed - indexed for MEDLINE]

12:

Management of morphologic changes associated with antiretroviral use in HIV-infected patients.

Wohl DA, Brown TT.

J Acquir Immune Defic Syndr. 2008 Sep 1;49 Suppl 2:S93-S100. Review.

PMID: 18725818 [PubMed - indexed for MEDLINE]

13:

HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.

Kotler DP.

J Acquir Immune Defic Syndr. 2008 Sep 1;49 Suppl 2:S79-85. Review.

PMID: 18725816 [PubMed - indexed for MEDLINE]

14:

The levator aponeurosis exposed.

Stack RR, Thompson AM, Weatherhead RG, Pithie A.

Ophthal Plast Reconstr Surg. 2008 Sep-Oct;24(5):426-8.

PMID: 18806677 [PubMed - indexed for MEDLINE]

15:

Suicide attempts among people living with HIV in France.

Préau M, Bouhnik AD, Peretti-Watel P, Obadia Y, Spire B; ANRS-EN12-VESPA Group.

AIDS Care. 2008 Sep;20(8):917-24.

PMID: 18777220 [PubMed - in process]

16:

Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection.

McComsey GA, Libutti DE, O'Riordan M, Shelton JM, Storer N, Ganz J, Jasper J, Harrill D, Gerschenson M.

Antivir Ther. 2008;13(5):715-22.

PMID: 18771055 [PubMed - indexed for MEDLINE]

17:

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.

Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, Ngeth C, Ferradini L, Delfraissy JF, Laureillard D.

Antivir Ther. 2008;13(5):697-703.

PMID: 18771053 [PubMed - indexed for MEDLINE]

18:

Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.

Zanone Poma B, Riva A, Nasi M, Cicconi P, Broggini V, Lepri AC, Mologni D, Mazzotta F, Monforte AD, Mussini C, Cossarizza A, Galli M; Icona Foundation Study Group.

AIDS. 2008 Sep 12;22(14):1769-78.

PMID: 18753860 [PubMed - indexed for MEDLINE]

19:

Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone.

Macallan DC, Baldwin C, Mandalia S, Pandol-Kaljevic V, Higgins N, Grundy A, Moyle GJ.

HIV Clin Trials. 2008 Jul-Aug;9(4):254-68.

PMID: 18753120 [PubMed - indexed for MEDLINE]

20:

Tesamorelin for fat accumulation. 52-week effects and safety of tesamorelin (growth hormone releasing factor) in HIV patients with fat accumulation.

Berger D.

Posit Aware. 2008 May-Jun;19(3):31. No abstract available.

PMID: 18724445 [PubMed - indexed for MEDLINE]

Recent Activity